Cristella Torres
Family Medicine · Omaha, NENPI 1609243013
Payments from drug & device makers
Across 97 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$413
- Actelion Pharmaceuticals US, Inc.$160
- Novo Nordisk$152
- Lilly USA, LLC$144
- Pfizer$140
- Biohaven Pharmaceuticals, Inc.$97
- plus $834 from 29 others
What the payments were for
- Food & beverage$1,84195%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $413 |
| Actelion Pharmaceuticals US, Inc. | 4 | $160 |
| Novo Nordisk | 9 | $152 |
| Lilly USA, LLC | 9 | $144 |
| Pfizer | 9 | $140 |
| Biohaven Pharmaceuticals, Inc. | 2 | $97 |
| Bayer | 4 | $65 |
| Astellas Pharma US Inc | 2 | $60 |
| Johnson & Johnson | 3 | $56 |
| Indivior Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Boehringer Ingelheim | 3 | $51 |
| Abbott | 3 | $44 |
| Exact Sciences | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Amgen | 2 | $30 |
| Radius Health, Inc. | 2 | $30 |
| Abiomed | 1 | $27 |
| Vertex | 1 | $26 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
| Cranial Technologies, Inc | 1 | $13 |
| GSK | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Organon | 1 | $5 |
How this compares
$1,940 in reported general payments places this provider in the 70th percentile of 981 family medicine providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $32,446 |
| JardianceEmpagliflozin | 16 | $14,452 |
| TrulicityDulaglutide | 15 | $13,976 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $13,426 |
| EliquisApixaban | 12 | $9,763 |
| Varenicline Tartrate | 18 | $5,751 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,198 |
| Atorvastatin Calcium | 112 | $787 |
| Omeprazole | 33 | $589 |
| Gabapentin | 39 | $559 |
| Fluticasone Propionate | 18 | $470 |
| Metformin Hcl | 40 | $227 |
| Levothyroxine Sodium | 25 | $222 |
| Bupropion XlBupropion Hcl | 11 | $206 |
| Duloxetine Hcl | 14 | $203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $152 | $32,44631 claims |
| Boehringer IngelheimJardiance | $51 | $14,45216 claims |
| Lilly USA, LLCTrulicity | $144 | $13,97615 claims |
| GSKTrelegy Ellipta | $13 | $13,42618 claims |
| PfizerEliquis | $140 | $9,76312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Omaha
- Kenneth BladOmaha$1.6M
- Ralph HaukeOmaha$657K
- Darin GregoryOmaha$423K
- Gregston NelsonOmaha$147K
- Birgit KhandalavalaOmaha$107K
- John HallgrenOmaha$94K
- Gerard StanleyOmaha$50K
- Kent JohnsonOmaha$16K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.